Mannheim

• A study in healthy people to see how zongertinib is taken up into the blood when given as tablets made by two different manufacturers Ended
  2023-510495-31-00 2 2024-04-24 Healthy volunteer trial
• A phase Ib/II single-arm, multicenter study of sacituzumab-govitecan, a TROP-2 targeting antibody linked with SN38, for patients with metast … Ended
  2023-505257-40-00 9 2024-04-17 metastatic esophagogastric adenocarcinoma (Stage IV)
• Peptide-coupled Red Blood Cells for the Treatment of Multiple Sclerosis Ended
  2023-510127-30-00 1 2024-04-17 Relapsing Remitting Multiple Sclerosis (RRMS)
• Bioequivalence study of the oral suspension of netupitant/palonosetron combination product versus the hard capsules of netupitant/palonosetr … Ended
  2023-504355-28-03 2 2024-03-14 Healthy volunteers
• A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control W … Ended
  2023-507206-13-00 5 2024-03-14 Type 2 Diabetes
• A Trial to Investigate TransCon TLR7/8 Agonist in Combination with Pembrolizumab, TransCon TLR7/8 Agonist in Combination with TransCon IL-2 … Ended
  2023-506092-10-00 4 2024-03-11 Stage III-IVA Resectable Locoregionall Advanced Head and Neck Squamous
• A study to learn if baxdrostat works at reducing blood pressure and is safe in people with high blood pressure Ended
  2023-505499-32-00 5 2024-03-08 Uncontrolled hypertension (uTHN) defined as blood pressure that remain
• A six-way relative bioavailability study comparing 10, 30, 40 and 50 mg leniolisib film coated tablets and 30 mg film coated granules with 7 … Ended
  2023-508880-61-00 3 2024-03-06 Activated Phosphoinositide 3-Kinase Delta Syndrome
• A study to test whether multiple doses of BI 456906 have an effect on cardiac safety in people with overweight or obesity. Ended
  2023-506375-10-00 3 2024-03-04 Healthy volunteer trial
• An open-label cocktail drug-drug interaction (DDI) clinical study to assess the effect of multiple oral dosing with leniolisib on the pharma … Ended
  2023-507134-25-00 3 2024-01-29 Activated Phosphoinositide 3-Kinase Delta Syndrome
• A study in healthy people to test whether iclepertin has an effect on cardiac safety Ended
  2023-504693-38-00 3 2024-01-25 Healthy
• Randomised, double-blind, placebo-controlled study to assess safety and efficacy of PRI-002 in patients with MCI or mild dementia due to Alz … Ended
  2022-503148-41-00 4 2023-12-01 Alzheimer's disease
• A large global trial to evaluate the efficacy and safety of milvexian in reducing recurrent cardiovascular events in patients after a heart … Ended
  2022-501418-69-00 5 2023-11-21 Acute Coronary Syndrome
• Safety, tolerability, and efficacy of ACOU085 for prevention of hearing loss in testicular cancer patients receiving cisplatin Ended
  2023-503696-15-00 4 2023-11-10 sensorineural hearing loss (SNHL)
• A Phase 3b, Open-label Study to Evaluate the Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents with Moderate-to-S … Ended
  2023-505558-16-00 5 2023-10-24 Atopic Dermatitis
• A study in healthy men to test whether carbamazepine influences the amount of BI 1810631 in the blood Ended
  2022-503046-50-00 3 2023-09-11 Healthy volunteer trial
• Study to Evaluate the Efficacy and Safety of Intranasal BPL-003 in Patients with Treatment Resistant Depression Ended
  2024-513457-70-00 4 2023-09-08 Treatment-Resistant Depression (TRD)
• A study to compare how different medicines (rosuvastatin, digoxin, metformin, and furosemide) are handled by the body of healthy people and … Ended
  2024-514621-29-00 3 2023-09-07 1. Patients with compensated liver cirrhosis due to any underlying liv
• INCB 39110-801 A Phase 2, Open-Label, Multicenter, Rollover Study to Provide Continued Treatment for Participants Previously Enrolled in Stu … Ended
  2022-501661-47-00 4 2023-08-23 Myelofibrosis ; postlung transplant (BOS); chronic graft-versus-host d
• Clinical trial of MK-7648A in adults and children with skin cancer Ended
  2022-501417-31-01 5 2023-08-01 melanoma
• Ecopipam Tablets to Study Tourette’s Disorder in Children, Adolescents and Adults (D1AMOND) Ended
  2023-503494-38-00 5 2023-07-20 Tourette’s Disorder
• A study to see how well CVGBM vaccine works at different doses and how safe it is in patients who had surgery for glioblastoma or astrocytom … Ended
  2022-501423-25-00 7 2023-05-05 Surgically Resected Glioblastoma (GBM) or Astrocytoma with a Molecular
• A study to compare how different substances (caffeine, warfarin, omeprazole, metoprolol, and midazolam) are handled by the body of healthy p … Ended
  2024-514622-22-00 3 2023-04-25 1. Patients with compensated liver cirrhosis due to any underlying liv
• Safety and immune responses after vaccination with two investigational RNA-based vaccines against tuberculosis in healthy volunteers Ended
  2023-509515-89-00 1 2023-04-14 Tuberculosis

Showing 289–312 of 355 trials